Advertisement
Screener

Quanterix Corporation (QTRX) Deferred Income Tax Expense (Benefit)

2.5 / 5 stars · 33/66 Roast Me

Quanterix Corporation Deferred Income Tax Expense (Benefit)

Quanterix Corporation (QTRX) reported Deferred Income Tax Expense (Benefit) of -$5.63 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-02

  • Quanterix Corporation deferred income tax expense (benefit) for fiscal 2025 was -$5.63M.
  • Quanterix Corporation deferred income tax expense (benefit) for fiscal 2024 was -$286.00K.
  • Quanterix Corporation deferred income tax expense (benefit) for fiscal 2023 was -$292.00K.
  • Quanterix Corporation deferred income tax expense (benefit) for fiscal 2022 was -$295.00K.
Period endDeferred Income Tax Expense (Benefit) 12 monthDeferred Income Tax Expense (Benefit) 12 month as first filed
2025-12-31-$5.63M
10-K · filed 2026-03-02
2024-12-31-$286.00K
10-K · filed 2026-03-02
2023-12-31-$292.00K
10-K · filed 2026-03-02
2022-12-31-$295.00K
10-K · filed 2025-03-17
-$380.00K
10-K · filed 2023-03-06
2021-12-31-$409.00K
10-K/A · filed 2024-12-26
-$408.00K
10-K · filed 2022-03-01
2020-12-31-$491.00K
10-K · filed 2023-03-06
2019-12-31-$300.00K
10-K · filed 2022-03-01
2018-12-31$7.00K
10-K · filed 2021-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15